文献速递药物不良反应与药物警戒

利用电子健康记录数据识别药物安全信号:范围综述

Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review.
PubMed 文献 · Drug Saf · 2023-06-20

该范围综述评估了基于电子健康记录(EHR)识别药物安全信号的现状,共纳入81项研究。研究发现不一致性方法占主导,其次为数据挖掘和回归;研究设计、数据元素、混杂调整和统计考虑差异大,直接比较困难。结论认为当前努力未能充分利用EHR数据的广度和深度,也未能严格控制的混杂,需建立最佳实践和通用数据模型。

要点

  • 基于EHR的药物安全信号识别研究以不一致性方法为主。
  • 研究设计差异大,直接比较困难。
  • 需建立最佳实践和通用数据模型以推广EHR药物警戒。

核心结论

  • 当前基于EHR的安全信号识别未能充分利用数据广度和深度,也未能严格控制的混杂。

研究设计与样本

  • 范围综述,纳入81项旨在从常规收集的患者层面EHR数据中识别安全信号的研究。

主要发现

  • 不一致性方法是主要分析方法,其次为数据挖掘和回归。
  • 研究在数据、混杂调整和统计考虑方面差异广泛,直接比较困难。

临床怎么用

  • 临床药学智能体医生在解读EHR药物安全信号时需注意研究设计和统计方法的异质性。

局限性

  • 研究设计变异性大,难以直接比较不同研究的结果。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Pharmacovigilance programs protect patient health and safety by identifying adverse event signals through postmarketing surveillance of claims data and spontaneous reports. Electronic health records (EHRs) provide new opportunities to address limitations of traditional approaches and promote discovery-oriented pharmacovigilance. METHODS: To evaluate the current state of EHR-based medication safety signal identification, we conducted a scoping literature review of studies aimed at identifying safety signals from routinely collected patient-level EHR data. We extracted information on study design, EHR data elements utilized, analytic methods employed, drugs and outcomes evaluated, and key statistical and data analysis choices. RESULTS: We identified 81 eligible studies. Disproportionality methods were the predominant analytic approach, followed by data mining and regression. Variability in study design makes direct comparisons difficult. Studies varied widely in terms of data, confounding adjustment, and statistical considerations. CONCLUSION: Despite broad interest in utilizing EHRs for safety signal identification, current efforts fail to leverage the full breadth and depth of available data or to rigorously control for confounding. The development of best practices and application of common data models would promote the expansion of EHR-based pharmacovigilance.

来源:Drug Saf,查看原文。版权归原作者所有。

引用

  1. Davis SE, Zabotka L, Desai RJ, et al. Use of Electronic Health Record Data for Drug Safety Signal Identification: A Scoping Review. Drug Saf. 2023. PMID: 37340238. doi:10.1007/s40264-023-01325-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。